A glucose-like metabolite, which is reduced in the serum of diabetic patients, inhibits the entry of SARS-CoV-2 into key cellular targets. The work led by Cheng and colleagues provides a molecular explanation for the increased risk of severe COVID-19 in patients with diabetes.

中文翻译：

---

糖尿病中的抗 SARS-CoV-2 代谢物减少

一种在糖尿病患者血清中减少的葡萄糖样代谢物可抑制 SARS-CoV-2 进入关键细胞靶标。Cheng 及其同事领导的工作为糖尿病患者患严重 COVID-19 的风险增加提供了分子解释。